- 科拓生物
- 16.760-0.390 (-2.274%)
盈利能力分析
- 4.217
- 5.357
- 5.451
- 8.250
- 11.531
- 3.953
- 5.065
- 5.191
- 7.760
- 10.739
- 4.157
- 5.268
- 5.361
- 8.085
- 11.344
邊際利潤分析
- 52.038
- 58.252
- 54.582
- 51.975
- 50.313
- 33.102
- 36.151
- 34.287
- 34.558
- 34.201
- 27.532
- 27.858
- 26.262
- 33.175
- 32.338
- 28.510
- 31.162
- 31.239
- 29.767
- 30.042
收益指標分析
- 90.383
- 83.943
- 87.848
- 89.411
- 77.507
- 3.227
- 5.138
- 7.237
- 7.433
- 10.599
- -0.017
- -0.583
- -0.549
- -1.529
- -0.427
償債能力分析
- 11.577
- 9.925
- 16.296
- 15.560
- 12.046
- 11.004
- 9.441
- 15.627
- 14.963
- 11.200
- 5.904
- 6.579
- 4.259
- 5.308
- 7.046
- -0.384
- -0.080
- 0.737
- 0.966
- 1.715
- -25,734.790
- -122,902.593
- 13,323.437
- 10,189.120
- 5,668.954
- 1,593.831
- 1,419.955
- 2,247.741
- 1,783.798
- 1,319.193
- -4.948
- -3.446
- -3.350
- -38.431
- -18.825
營運能力分析
- 61.454
- 72.447
- 101.453
- 106.466
- 115.992
- 99.880
- 122.204
- 119.403
- 105.367
- 96.953
回顧25 展望26
貨幣攻略
More